Merkel Cell Carcinoma
Conditions
Keywords
Merkel Cell Carcinoma
Brief summary
Taking part in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of Merkel cell carcinoma patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Merkel cell carcinoma patients.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Aged ≥ 18 years old * Able to comprehend the investigational nature of the protocol and provide informed consent * Diagnosis of Merkel cell carcinoma
Exclusion criteria
* No diagnosis of Merkel cell carcinoma confirmed * Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of patients who decide to enroll in a Merkel cell carcinoma clinical research | 3 months |
| Rate of patients who remain in Merkel cell carcinoma clinical research to trial completion | 12 months |
Countries
United States
Contacts
Primary ContactMichael B Gill
Outcome results
None listed